Lacoste; Jean-Eric
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lacoste; Jean-Eric.The latest application filed is for "imidazopyridazines useful as inhibitors of the par-2 signaling pathway".
- Lacoste; Jean-Eric - Laval CA
- Lacoste; Jean-Eric - Laval Quebec
| Patent | Date |
|---|---|
| Imidazopyridazines Useful As Inhibitors Of The Par-2 Signaling Pathway App 20190119282 - Farmer; Luc J. ; et al. | 2019-04-25 |
| Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway Grant 10,030,024 - Farmer , et al. July 24, 2 | 2018-07-24 |
| Bicyclic Heteroaryl Compounds Useful As Inhibitors Of The Par-2 Signaling Pathway App 20180057505 - SAYEGH; Camil Elie ; et al. | 2018-03-01 |
| Inhibitors of cytomegalovirus Grant 9,505,775 - Thibeault , et al. November 29, 2 | 2016-11-29 |
| Imidazopyridazines Useful As Inhibitors Of The Par-2 Signaling Pathway App 20160311825 - Farmer; Luc J. ; et al. | 2016-10-27 |
| Inhibitors of HIV replication Grant 9,399,645 - Sturino , et al. July 26, 2 | 2016-07-26 |
| Inhibitors Of Cytomegalovirus App 20150274744 - Thibeault; Carl ; et al. | 2015-10-01 |
| Inhibitors Of Hiv Replication App 20150011531 - Sturino; Claudio ; et al. | 2015-01-08 |
| Inhibitors of HIV replication Grant 8,349,839 - Sturino , et al. January 8, 2 | 2013-01-08 |
| Enantiomeric Resolution Of 2,4-disubstituted 1,3-oxathiolane Nucleosides App 20120184739 - Vizititu; Dragos ; et al. | 2012-07-19 |
| Inhibitors Of Hiv Replication App 20100261714 - STURINO; Claudio ; et al. | 2010-10-14 |
| Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides Grant 7,501,514 - Vizitiu , et al. March 10, 2 | 2009-03-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 